novartis glp-1 receptor agonist weight management diabetes treatments GLP-1 Medications for Weight Loss: Semaglutide Repurposing glucagon-like peptide-1 receptor agonists
Description
Ozempic is approved only for Type 2 diabetes, not weight loss
Messineo L et al
Some formulations may also use more bioavailable nutrient forms that fit better into reduced intake patterns
baseline weight and the quantity and speed of loss
This novel approach to the development of MEDI7219 provides a template for the development of other oral peptide therapeutics
doi: 10.1038/s42255-020-0171-3 41 TschpMHFinanBClemmensenCGelfanovVPerez-TilveDMllerTDet al
